Groundbreaking Alzheimer’s drug not cost-effective ‘at any price’ – NCPE
By Michael McHale 17th October 2026 0 “We know that this news will be disappointing for families affected by dementia,” says Alzheimer Society of Ireland. The HSE should not consider reimbursing a ground-breaking drug found to slow disease progression in patients with early-stage…